{"title":"<i>Bacillus coagulans</i> restores pathogen-induced intestinal dysfunction via acetate-FFAR2-NF-κB-MLCK-MLC axis in <i>Apostichopus japonicus</i>.","authors":"Mingshan Song, Shanshan Zhang, Zhen Zhang, Liyuan Guo, Weikang Liang, Chenghua Li, Zhonghua Wang","doi":"10.1128/msystems.00602-24","DOIUrl":null,"url":null,"abstract":"<p><p>Skin ulceration syndrome (SUS) is currently the main disease threatening <i>Apostichopus japonicus</i> aquaculture due to its higher mortality rate and infectivity, which is caused by <i>Vibrio splendidus</i>. Our previous studies have demonstrated that SUS is accompanied by intestinal microbiota (IM) dysbiosis, alteration of short-chain fatty acids (SCFAs) content and the damage to the intestinal barrier. However, the mediating effect of IM on intestine dysfunction is largely unknown. Herein, we conducted comprehensive intestinal microbiota transplantation (IMT) to explore the link between IM and SUS development. Furthermore, we isolated and identified a <i>Bacillus coagulans</i> strain with an ability to produce acetic acid from both healthy individual and SUS individual with IM from healthy donors. We found that dysbiotic IM and intestinal barrier function in SUS recipients <i>A. japonicus</i> could be restored by IM from healthy donors. The <i>B. coagulans</i> strain could restore IM community and intestinal barrier function. Consistently, acetate supply also restores intestinal homeostasis of SUS-diseased and <i>V. splendidus</i>-infected <i>A. japonicus</i>. Mechanically, acetate was found to specifically bind to its receptor-free fatty acid receptor 2 (FFAR2) to mediate IM structure community and intestinal barrier function. Knockdown of FFAR2 by transfection of specific FFAR2 siRNA could hamper acetate-mediated intestinal homeostasis <i>in vivo</i>. Furthermore, we confirmed that acetate/FFAR2 could inhibit <i>V. splendidus</i>-activated NF-κB-MLCK-MLC signaling pathway to restore intestinal epithelium integrity and upregulated the expression of ZO-1 and Occludin. Our findings provide the first evidence that <i>B. coagulans</i> restores pathogen-induced intestinal barrier dysfunction via acetate/FFAR2-NF-κB-MLCK-MLC axis, which provides new insights into the control and prevention of SUS outbreak from an ecological perspective.IMPORTANCESkin ulceration syndrome (SUS) as a main disease in <i>Apostichopus japonicus</i> aquaculture has severely restricted the developmental <i>A. japonicus</i> aquaculture industry. Intestinal microbiota (IM) has been studied extensively due to its immunomodulatory properties. Short-chain fatty acids (SCFAs) as an essential signal molecule for microbial regulation of host health also have attracted wide attention. Therefore, it is beneficial to explore the link between IM and SUS for prevention and control of SUS. In the study, the contribution of IM to SUS development has been examined. Additionally, our research further validated the restoration of SCFAs on intestinal barrier dysfunction caused by SUS via isolating SCFAs-producing bacteria. Notably, this restoration might be achieved by inhibition of NF-κB-MLCK-MLC signal pathway, which could be activated by <i>V. splendidus</i>. These findings may have important implications for exploration of the role of IM in SUS occurrence and provide insight into the SUS treatment.</p>","PeriodicalId":18819,"journal":{"name":"mSystems","volume":null,"pages":null},"PeriodicalIF":5.0000,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11265352/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"mSystems","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1128/msystems.00602-24","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Skin ulceration syndrome (SUS) is currently the main disease threatening Apostichopus japonicus aquaculture due to its higher mortality rate and infectivity, which is caused by Vibrio splendidus. Our previous studies have demonstrated that SUS is accompanied by intestinal microbiota (IM) dysbiosis, alteration of short-chain fatty acids (SCFAs) content and the damage to the intestinal barrier. However, the mediating effect of IM on intestine dysfunction is largely unknown. Herein, we conducted comprehensive intestinal microbiota transplantation (IMT) to explore the link between IM and SUS development. Furthermore, we isolated and identified a Bacillus coagulans strain with an ability to produce acetic acid from both healthy individual and SUS individual with IM from healthy donors. We found that dysbiotic IM and intestinal barrier function in SUS recipients A. japonicus could be restored by IM from healthy donors. The B. coagulans strain could restore IM community and intestinal barrier function. Consistently, acetate supply also restores intestinal homeostasis of SUS-diseased and V. splendidus-infected A. japonicus. Mechanically, acetate was found to specifically bind to its receptor-free fatty acid receptor 2 (FFAR2) to mediate IM structure community and intestinal barrier function. Knockdown of FFAR2 by transfection of specific FFAR2 siRNA could hamper acetate-mediated intestinal homeostasis in vivo. Furthermore, we confirmed that acetate/FFAR2 could inhibit V. splendidus-activated NF-κB-MLCK-MLC signaling pathway to restore intestinal epithelium integrity and upregulated the expression of ZO-1 and Occludin. Our findings provide the first evidence that B. coagulans restores pathogen-induced intestinal barrier dysfunction via acetate/FFAR2-NF-κB-MLCK-MLC axis, which provides new insights into the control and prevention of SUS outbreak from an ecological perspective.IMPORTANCESkin ulceration syndrome (SUS) as a main disease in Apostichopus japonicus aquaculture has severely restricted the developmental A. japonicus aquaculture industry. Intestinal microbiota (IM) has been studied extensively due to its immunomodulatory properties. Short-chain fatty acids (SCFAs) as an essential signal molecule for microbial regulation of host health also have attracted wide attention. Therefore, it is beneficial to explore the link between IM and SUS for prevention and control of SUS. In the study, the contribution of IM to SUS development has been examined. Additionally, our research further validated the restoration of SCFAs on intestinal barrier dysfunction caused by SUS via isolating SCFAs-producing bacteria. Notably, this restoration might be achieved by inhibition of NF-κB-MLCK-MLC signal pathway, which could be activated by V. splendidus. These findings may have important implications for exploration of the role of IM in SUS occurrence and provide insight into the SUS treatment.
皮肤溃疡综合征(SUS)是目前威胁日本狎鸥鱼养殖的主要疾病,因其死亡率和感染性较高,由绚丽弧菌引起。我们之前的研究表明,SUS伴随着肠道微生物群(IM)失调、短链脂肪酸(SCFAs)含量的改变和肠道屏障的破坏。然而,IM 对肠道功能障碍的介导作用在很大程度上是未知的。在此,我们进行了全面的肠道微生物群移植(IMT),以探索 IM 与 SUS 发生之间的联系。此外,我们还从健康个体和SUS个体的健康供体中分离并鉴定出了具有产生醋酸能力的凝结芽孢杆菌菌株。我们发现,健康供体的 IM 可以恢复 SUS 受体 A. japonicus 中菌群失调的 IM 和肠道屏障功能。凝结芽孢杆菌菌株可以恢复肠内生物群落和肠道屏障功能。同样,醋酸盐也能恢复 SUS 疾病和白芨感染的日本豚鼠的肠道平衡。在机制上,研究发现醋酸与其无受体的脂肪酸受体 2(FFAR2)特异性结合,以介导 IM 结构群落和肠屏障功能。通过转染特异性 FFAR2 siRNA 来敲除 FFAR2 可阻碍醋酸介导的体内肠道平衡。此外,我们还证实醋酸/FFAR2能抑制白芨激活的NF-κB-MLCK-MLC信号通路,从而恢复肠上皮细胞的完整性,并上调ZO-1和Occludin的表达。我们的研究结果首次证明了凝结芽孢杆菌可通过醋酸酯/FFAR2-NF-κB-MLCK-MLC 轴恢复病原体诱导的肠屏障功能障碍,这为从生态学角度控制和预防 SUS 的爆发提供了新的见解。 重要意义皮肤溃疡综合征(SUS)作为日本狎鸥鱼养殖过程中的一种主要疾病,严重制约了日本狎鸥鱼养殖业的发展。肠道微生物群(IM)因其免疫调节特性而被广泛研究。短链脂肪酸(SCFAs)作为微生物调节宿主健康的重要信号分子也引起了广泛关注。因此,探讨 IM 与 SUS 之间的联系有利于预防和控制 SUS。本研究探讨了 IM 对 SUS 发展的贡献。此外,我们的研究还通过分离产生 SCFAs 的细菌,进一步验证了 SCFAs 对 SUS 引起的肠屏障功能障碍的修复作用。值得注意的是,这种修复作用可能是通过抑制芨芨草菌激活的 NF-κB-MLCK-MLC 信号通路实现的。这些发现可能对探索 IM 在 SUS 发生中的作用具有重要意义,并为 SUS 的治疗提供了启示。
mSystemsBiochemistry, Genetics and Molecular Biology-Biochemistry
CiteScore
10.50
自引率
3.10%
发文量
308
审稿时长
13 weeks
期刊介绍:
mSystems™ will publish preeminent work that stems from applying technologies for high-throughput analyses to achieve insights into the metabolic and regulatory systems at the scale of both the single cell and microbial communities. The scope of mSystems™ encompasses all important biological and biochemical findings drawn from analyses of large data sets, as well as new computational approaches for deriving these insights. mSystems™ will welcome submissions from researchers who focus on the microbiome, genomics, metagenomics, transcriptomics, metabolomics, proteomics, glycomics, bioinformatics, and computational microbiology. mSystems™ will provide streamlined decisions, while carrying on ASM''s tradition of rigorous peer review.